Aurobindo Pharma informs about audited financial results

18 Jun 2018 Evaluate

With reference to the letter dated 28th May, 2018 wherein the company has intimated the schedule of Investors/Analysts call on 29th May, 2018, Aurobindo Pharma has informed about submission of transcript of the analyst / investor call on the Audited Financial Results of the Company for the Year ended 31st March, 2018 of 29th May, 2018 and the same is being uploaded on the website of the Company and is available in the following web link: http://www.aurobindo.com/docs/financial-results/2017-2018/aurobindo-pharma-q4-fy-18-earnings-call-transcript.pdf.

The above information is a part of company’s filings submitted to BSE.

 

Aurobindo Pharma Share Price

1266.65 14.60 (1.17%)
07-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1507.00
Dr. Reddys Lab 6037.55
Cipla 1497.30
Zydus Lifesciences 1058.45
Lupin 1630.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.